<DOC>
	<DOCNO>NCT01733693</DOCNO>
	<brief_summary>The purpose study ( 1 ) compare effect buprenorphine methadone , two type opioid addiction treatment , ability think reason among people addict opiate , either HIV negative HIV positive ; ( 2 ) investigate whether HIV infection change way opioid treatment affect ability think reason . The investigator hypothesize ( 1 ) significant improvement think reason ability start buprenorphine treatment compare methadone treatment , among participant without HIV 2 4 month compare baseline ; ( 2 ) HIV positive participant demonstrate significant improvement think reason ability 2 4 month compare baseline , think reason ability still low HIV negative participant .</brief_summary>
	<brief_title>Neurocognitive Effects Opiate Agonist Treatment</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Age 18 68 English Spanish speaking Documentation HIV Status Opioiddependent without receive medication treatment opioid dependence within previous 90 day Negative pregnancy test , woman No `` street '' use methadone buprenorphine Willing participate study component Able provide inform consent Education &gt; 6 year Not acutely intoxicate Serious unstable medical disease : liver disease ( AST ALT â‰¥ 3x ULN , elevate PT/INR , albumin &lt; 3.0 g/dl evidence decompensated cirrhosis ) ; Severe cardiovascular disease ( MI , PTCA , unstable angina , CABG , and/or serious arrhythmia previous 6 month ) ; COPD ( require supplemental oxygen hospitalization past 6 month ) ; End stage renal disease creatinine clearance &lt; 30 mL/min Neurological disease : head injury LOC &gt; 24 hour , previous penetrate skull wound , focal brain lesion , history neurosurgery , seizure disorder ( ETOHrelated ) , nonHIV CNS opportunistic infection Psychiatric disorder ( schizophrenia bipolar ) Benzodiazepine alcohol dependence Chronic pain condition require opioid analgesic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Buprenorphine</keyword>
	<keyword>Methadone</keyword>
	<keyword>Cognition</keyword>
</DOC>